HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frédérique Gaits-Iacovoni Selected Research

phosphatidylinositol 5-phosphate

6/2014Phosphatidylinositol 5-phosphate regulates invasion through binding and activation of Tiam1.
9/2011Shigella flexneri infection generates the lipid PI5P to alter endocytosis and prevent termination of EGFR signaling.
9/2009PtdIns5P protects Akt from dephosphorylation through PP2A inhibition.
3/2006PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frédérique Gaits-Iacovoni Research Topics

Disease

4Neoplasms (Cancer)
06/2016 - 09/2010
3Thrombosis (Thrombus)
01/2018 - 01/2016
3Infections
01/2012 - 03/2006
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2011 - 05/2006
2Lymphoma (Lymphomas)
06/2014 - 09/2010
1Inflammation (Inflammations)
01/2018
1Sepsis (Septicemia)
01/2018
1Communicable Diseases (Infectious Diseases)
06/2016
1Obesity
03/2016
1Immune System Diseases (Immune Disorders)
01/2016
1Congenital Structural Myopathies (Centronuclear Myopathy)
12/2014
1Bacterial Infections (Bacterial Infection)
06/2014
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2013
1Dysentery
09/2011
1Bacillary Dysentery (Shigellosis)
09/2009
1Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2006

Drug/Important Bio-Agent (IBA)

4LipidsIBA
01/2018 - 09/2011
4Phosphatidylinositols (Phosphatidylinositol)IBA
06/2016 - 09/2011
4phosphatidylinositol 5-phosphateIBA
06/2014 - 03/2006
4Anaplastic Lymphoma KinaseIBA
06/2014 - 05/2006
3Phosphotransferases (Kinase)IBA
11/2017 - 01/2016
3Proteins (Proteins, Gene)FDA Link
12/2014 - 05/2006
2NucleophosminIBA
09/2011 - 05/2006
2Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
09/2009 - 03/2006
11- ((2- ((2- chloropyridin- 4yl)amino)- 4'- (cyclopropylmethyl)- (4,5'- bipyrimidin)- 2'- yl)amino)- 2- methylpropan- 2- olIBA
11/2017
1SAR405IBA
11/2017
1EnzymesIBA
06/2016
1Pharmaceutical PreparationsIBA
01/2016
1Protein Isoforms (Isoforms)IBA
01/2016
1Dynamins (Dynamin)IBA
12/2014
1Phosphatidylinositol 4,5-Diphosphate (Phosphatidylinositol 4,5 Diphosphate)IBA
12/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
06/2014
1Phosphoinositide PhosphatasesIBA
09/2011
1Pyridinolcarbamate (P23)IBA
09/2011
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2011
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
09/2010
1Matrix Metalloproteinases (MMPs)IBA
09/2010
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2010